Ains: Human telomerase reverse transcriptase (hTERT) is believed to a reliable marker for telomerase activity. The expression of telomerase activity has not been investigated in a consecutive series of patients with colorectal adenocarcinoma in North Queensland. The objective of this study was to evaluate the significance of hTERT mRNA expression in colorectal adenocarcinoma in North Queensland. 
Introduction
Proliferation of the cells is carefully regulated by many factors such as gene controlled cell division, repair, and apoptosis. Break down in one of the regulation controls occasionally happens due to viral infection, DNA methylation, and sequence alteration. This leads to unregulated cell division fashion and ultimately forms a tumour. Colorectal cancer is one of the common diseases, which is developed in a multi-step process and associated with genetic alterations (1, 2) . One of the characteristic features of cancer is telomerase activation.
Human telomerase is a ribonucloprotein composed of two components, human telomerase RNA (hTR) and human telomerase reverse transcriptase (hTERT). Both components are essential for telomerase activity. This unique enzyme uses its RNA as a template to add telomeric repeats at the end of chromosome ends in order to compensate for telomere loss during cell division (3, 4) . The cell is able to continue proliferation because telomerase stabilizes the chromosome ends from degradation and fusion. It is believed that telomerase reactivation in the cell is associated with carcinogenesis and is a critical step in the tumour immortalization process (5-7).
Telomerase activity has been found in more than 85% of all human tumours, as well as germ and stem cells. In normal cells, it is either low or undetectable level. A polymerase chain reaction (PCR)-based method, telomeric repeat amplification protocol (TRAP) assay, has been developed to detect telomerase activity (8, 9) . hTERT expression is restricted to cancer cells and closely associated to telomerase activity. This indicates that hTERT expression is the ratelimiting determinant of telomerase and could be used as means of measuring telomerase activity (10) (11) (12) . In colorectal cancer, conflicting results have been reported for telomerase activation and its correlation with clinical parameters. Despite absence of telomerase in normal mucosa, these studies have demonstrated the activation of telomerase occurs in adenomas and telomerase level is further increased in carcinomas (13, 14) . Other reports revealed a detectable level of telomerase activity in normal mucosa (15) (16) (17) . A few studies have shown a significant association between telomerase and clinicopathological features during cancer progression (16) (17) (18) , whereas others failed to find such a relationship (13, 15) .
Although telomerase activity has been detected in colorectal cancer, much remains unknown about hTERT expression and correlation to tumour progression and clincopathological features. In this study, we evaluated expression level of hTERT mRNA in tumour tissues and corresponding adjacent non-tumour mucosa from patients with colorectal adenocarcinomas and adenomas by using real-time reverse transcriptase polymerase chain reaction. We also analyzed the relationship between hTERT expression level and clinicopathological features of the patients.
Materials and Methods

Patient selection and sample collection
Patients with histologically confirmed colon and rectal tumours were prospectively and consecutively recruited into the study. Consent was given according to the hospital human ethics committee approval. The clinical diagnostic, staging, surgical and pathological data were collected in a standardized manner, using a computerized database. Management was by a preagreed standardized multidisciplinary protocol supervised by a senior specialist colorectal surgeon. None of the rectal cancer patients had undergone neoadjuvant radiotherapy or chemotherapy prior to surgery. Pathological diagnosis was also standardized and reviewed by committee criteria, chaired by a senior academic pathologist with a special interest in the field.
At the time of surgery, the tissue from the tumour and normal colorectal mucosa from the proximal resection margin were promptly sampled from the resected specimen. These samples were preserved in RNAlater (Ambion, Austin, TX, USA) within 10 minutes of surgery to prevent degradation of the RNA. They were stored at -80 0 C for the experiment.
RNA extraction
Total RNA was extracted from the 10-25 mg of tested tissue by disruption and homogenization using High Pure RNA Tissue Kit (Roche Diagnostics, Mannheim, Germany).
DNase I was used to digest DNA contamination. Quality of the RNA was checked by agarose gel electrophoresis to rule out degraded RNA. 
Primers and probes
The primer set and probe for amplification of hTERT (GenBank accession number AF015950) and GAPDH, (GenBank accession number NM_002046) genes were designed using GenScript web site/design tool (www.genscript.com/ssl-bin/app/primer) ( Table 1 ). The primers for both genes, placed in different exons, were checked by conventional PCR to ensure they did not amplify genomic DNA. The probes contained 6-carboxyflourscein (FAM) as fluorescent reporter dye, and 6-carboxytetramethyl-rhodamine (TAMRA) as quencher for its light emission spectrum. These probes were purchased from Sigma Genosys (Wollands, TX, USA). During the extension phase of PCR, the probe hybridized to the target sequence and was then cleaved due to the 5' to 3' exonuclease activity of Taq polymerase. The increase in fluorescence signal of the reporter was proportional to the amount of specific PCR products, providing highly accurate and reproducible quantification. (Table 3) . Thus, significant difference was found between hTERT expression and the location of the tumour (P=0.029).
Discussion
Telomerase activity is strongly linked with the development of tumour and may play a critical role as a biomarker for early detection of cancer. TRAP assay has been used to detect telomerase activity. Recently, real time PCR has been used to detect and evaluate hTERT mRNA. It is a powerful, accurate, specific, and sensitive method to measure the level of hTERT transcript (19, 20) . In vitro, the minimum requirements for active telomerase are two components, hTER and hTERT, the presence of telomerase inhibitors such as proteases or RNases in tissue extract may affect the outcome sensitivity of the TRAP assay (20) . Also evaluation of the copy numbers of hTERT mRNA by real time PCR makes statistical analysis more appropriate.
Early reports have detected telomerase activity, measured by TRAP assay, in colorectal carcinomas but not in normal mucosa (13, 14, 21) . Recently, telomerase activity or hTERT expression has been demonstrated in normal mucosa (16, 17, 20) . hTERT was also found to be expressed in non-tumour colorectal tissues by immunohistochemistry (24) . A quantitative study found expression level of hTERT mRNA was higher in adjacent non-tumour than in tumour tissues, and 21% of 57 tumour samples were expressed higher hTERT mRNA than in nontumour samples (25) . In concurrence with the recent literature, we showed that telomerase activity, as expressed by hTERT copy number, was noted in normal tissue, adenoma and adenocarcinoma from the colon and the rectum (16, 17, 20, 25) . More than half of the adenocarcinomas expressed higher level of hTERT than the morphological normal mucosa. The level of expression of hTERT in the colorectal adenocarcinomas was also slightly higher than in the adenomas though the difference did not reach statistical significant level.
The presence of hTERT mRNA in adjacent non-tumour colorectal mucosa could be explained by different hypothesis. Alternative splicing of hTERT transcript has been reported to regulate telomerase activity. Therefore, expression of hTERT transcript may not reflect the actual level of telomerase in non-tumour tissues (26) . Infiltrating activated lymphocytes or cancer cells may also affect the outcome of hTERT. As telomerase is a common feature of abnormal epithelial cell proliferation during cancer development, expression of hTERT mRNA in non-tumour tissues may not be sufficient to activate telomerase (26) . In this study, the presence of telomerase hTERT in dysplastic mucosa (adenoma) suggests that telomerase is activated early in the carcinogenesis. Thus, in morphological non-tumour colorectal mucosa, the presence of low level of telomerase hTERT may indicate that carcinogenesis start in this mucosa before any detectable morphological changes noted by pathologists.
In the literature, conflicting results were reported for correlation of telomerase or hTERT expression with clinical and pathological parameters (15, 18, 22) . Some studies carried out in colorectal cancer have correlated presence of telomerase expression either with depth of tumour (pT) (16, 22) , tumour grade (17, 25) , or with stage (18) . Other studies found no correlation between telomerase expression and prognosis despite steady increased in telomerase expression during cancer development (13, 15, 27) . In this study, hTERT level in colorectal adenocarcinomas was not related to the age and gender of the patients. The quantitative results revealed that the hTERT mRNA level was increased in tumour carcinomas during cancer progression from normal morphology to dysplastic tissue (adenoma) to cancer (adenocarcinoma). However, our data did not confirm the statistical difference between hTERT mRNA expression and tumour status, lymph node, stage and grade. In tumour with distant metastases, the level of telomerase hTERT expression was significantly increased in tumour tissue samples when compared with normal, but no statistical correlation was found. This result should be interpreted with caution due to small number of samples with distant metastases (n=3).
In the recent years, researchers have demonstrated that cancers located in the right (proximal) and left (distal) colorectum can be distinguished by clinical and molecular criteria [28] [29] [30] . Proximal colorectal tumours, when compared to distal tumours, were more often found in older age, females and benefit from 5-fluorouracil-based-chemotherapy. Right sided tumours also showed significantly less nuclear β-catenin and p53 overexpression than left-sided tumours [28] [29] [30] . In this study, a significant difference was found between hTERT expression and the location of the tumour (p=0.029), which indicates that proximal tumours in the colorectum are more likely to be low hTERT expression than the distal tumours. This is the first study reporting statistical significance between hTERT mRNA expression and the 2 clinical 
